Tingwei Su

1.2k total citations
52 papers, 659 citations indexed

About

Tingwei Su is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Tingwei Su has authored 52 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 29 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Cancer Research. Recurrent topics in Tingwei Su's work include Adrenal and Paraganglionic Tumors (26 papers), Hormonal Regulation and Hypertension (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Tingwei Su is often cited by papers focused on Adrenal and Paraganglionic Tumors (26 papers), Hormonal Regulation and Hypertension (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Tingwei Su collaborates with scholars based in China, United States and Australia. Tingwei Su's co-authors include Weiqing Wang, Lei Jiang, Weiwei Zhou, Guang Ning, Guang Ning, Yiran Jiang, Min Xu, Lei Ye, Biao Li and Qidi Wang and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Cellular Physiology.

In The Last Decade

Tingwei Su

51 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tingwei Su China 15 322 270 137 135 103 52 659
Sofia S. Pereira Portugal 14 176 0.5× 341 1.3× 175 1.3× 144 1.1× 154 1.5× 70 654
Holger S. Willenberg Germany 15 340 1.1× 307 1.1× 58 0.4× 274 2.0× 129 1.3× 37 820
Marie Helene Schernthaner-Reiter Austria 17 278 0.9× 189 0.7× 119 0.9× 303 2.2× 45 0.4× 36 841
Stephen M. Orme United Kingdom 4 702 2.2× 189 0.7× 74 0.5× 136 1.0× 41 0.4× 6 774
Aparna Pal United Kingdom 11 283 0.9× 162 0.6× 61 0.4× 218 1.6× 67 0.7× 32 557
Andreas Moraitis United States 14 309 1.0× 228 0.8× 33 0.2× 143 1.1× 123 1.2× 41 565
Susana Igreja United Kingdom 10 418 1.3× 187 0.7× 65 0.5× 274 2.0× 121 1.2× 14 724
Kenji Ashida Japan 16 243 0.8× 89 0.3× 71 0.5× 155 1.1× 52 0.5× 72 683
Nozomi Fukai Japan 15 179 0.6× 197 0.7× 81 0.6× 178 1.3× 47 0.5× 18 578
Takuyuki Katabami Japan 16 651 2.0× 470 1.7× 44 0.3× 97 0.7× 71 0.7× 60 840

Countries citing papers authored by Tingwei Su

Since Specialization
Citations

This map shows the geographic impact of Tingwei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingwei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingwei Su more than expected).

Fields of papers citing papers by Tingwei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingwei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingwei Su. The network helps show where Tingwei Su may publish in the future.

Co-authorship network of co-authors of Tingwei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Tingwei Su. A scholar is included among the top collaborators of Tingwei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingwei Su. Tingwei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ming‐Hui, Jianguo Zhu, Tingwei Su, et al.. (2024). Assessment of Optical Attenuation and Skin Thickness in Type 2 Diabetes Mellitus Patients Using Optical Coherence Tomography. Journal of Biophotonics. 17(12). e202400267–e202400267. 1 indexed citations
2.
Su, Tingwei, Yifan Yang, Lei Jiang, et al.. (2023). SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis. Frontiers in Endocrinology. 14. 1121397–1121397. 6 indexed citations
3.
Zhou, Lihua, Yiran Jiang, Cui Zhang, et al.. (2023). Effects of a low-sodium diet in patients with idiopathic hyperaldosteronism: a randomized controlled trial. Frontiers in Endocrinology. 14. 1124479–1124479. 6 indexed citations
4.
Zhu, Hongyuan, Tingwei Su, Lei Jiang, et al.. (2023). Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors. Frontiers in Endocrinology. 14. 1199875–1199875. 2 indexed citations
5.
Jiang, Yiran, et al.. (2021). Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism. Frontiers in Molecular Biosciences. 8. 751770–751770. 6 indexed citations
6.
Cai, Rongrong, Weiwei Zhou, Lei Jiang, et al.. (2020). Association between thyroid function and serum cortisol in cortisol-producing adenoma patients. Endocrine. 69(1). 196–203. 8 indexed citations
7.
Ye, Lei, Tingwei Su, Jing Xie, et al.. (2017). Establishment and evaluation of a novel biomarker‐based nomogram for malignant phaeochromocytomas and paragangliomas. Clinical Endocrinology. 87(2). 127–135. 8 indexed citations
8.
Wang, Weiqing, Lei Ye, Tingwei Su, et al.. (2016). ERBB‐2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas. Clinical Endocrinology. 84(6). 822–829. 7 indexed citations
9.
Wang, Weiqing, Shuwei Wang, Yiran Jiang, et al.. (2015). Relationship between pituitary stalk ( PS ) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited. Clinical Endocrinology. 83(3). 369–376. 22 indexed citations
10.
Ye, Lei, Xiaohua Jiang, Tingwei Su, et al.. (2015). Syndrome of inappropriate secretion of TSH: Differential diagnosis in 61 patients. Zhonghua neifenmi daixie zazhi. 31(11). 925–931. 2 indexed citations
11.
Wang, Weiqing, Tingwei Su, Lei Ye, et al.. (2015). Plasma Metanephrines Are Associated With Glucose Metabolism in Patients With Essential Hypertension. Medicine. 94(37). e1496–e1496. 4 indexed citations
12.
Cai, Jie, Lin Li, Lei Ye, et al.. (2014). Exome sequencing reveals mutant genes with low penetrance involved in MEN2A-associated tumorigenesis. Endocrine Related Cancer. 22(1). 23–33. 9 indexed citations
13.
Zhū, Lìyǐng, Tingwei Su, Min Xu, et al.. (2013). Eosinophil Inversely Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults. PLoS ONE. 8(7). e67613–e67613. 28 indexed citations
14.
Sun, Kan, Tingwei Su, Mian Li, et al.. (2013). Serum potassium level is associated with metabolic syndrome: A population-based study. Clinical Nutrition. 33(3). 521–527. 27 indexed citations
15.
Wang, Qidi, Min Zhang, Guang Ning, et al.. (2011). Brown Adipose Tissue in Humans Is Activated by Elevated Plasma Catecholamines Levels and Is Inversely Related to Central Obesity. PLoS ONE. 6(6). e21006–e21006. 118 indexed citations
16.
Zhu, Yu, Hongchao He, Tingwei Su, et al.. (2010). Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocrine. 38(2). 254–259. 35 indexed citations
17.
Zheng, Xulei, Weiqing Wang, Tingwei Su, et al.. (2009). Mutation of SDHB gene in sporadic patients with pheochromocytom. Zhonghua neifenmi daixie zazhi. 25(4). 423–425. 1 indexed citations
18.
19.
Su, Tingwei, et al.. (2007). A primary right atrium paraganglioma in a 15-year-old patient. Endocrine. 32(2). 245–248. 9 indexed citations
20.
Wang, Weiqing, Lei Jiang, Lei Ye, et al.. (2006). Mutation screening in Chinese hypokalemic periodic paralysis patients. Molecular Genetics and Metabolism. 87(4). 359–363. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia S. Pereira Breakdown of academic impact, for papers by Holger S. Willenberg Breakdown of academic impact, for papers by Marie Helene Schernthaner-Reiter Breakdown of academic impact, for papers by Stephen M. Orme Breakdown of academic impact, for papers by Aparna Pal Breakdown of academic impact, for papers by Andreas Moraitis Breakdown of academic impact, for papers by Susana Igreja Breakdown of academic impact, for papers by Kenji Ashida Breakdown of academic impact, for papers by Nozomi Fukai Breakdown of academic impact, for papers by Takuyuki Katabami
Rankless by CCL
2026